Picture of Immuno-Biological Laboratories logo

4570 — Immuno-Biological Laboratories News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapFalling Star

Table: Immuno Biological Lab - 6-MTH group results

Nov 13 (Reuters)- 
             Immuno Biological Laboratories Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2025        Sep 30, 2024     Mar 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            485 mln             444 mln           1.03     
                 (+9.3 pct)          (+21.5 pct)      (+5.7 pct)  
  Operating        142 mln             68 mln           240 mln   
                (+109.0 pct)        (+411.3 pct)      (+14.6 pct) 
  Recurring        149 mln             64 mln           240 mln   
                (+133.4 pct)        (+109.6 pct)      (+14.4 pct) 
  Net              141 mln             71 mln           265 mln   
                 (+98.0 pct)        (+166.2 pct)      (+6.4 pct)  
  EPS             15.21 yen           7.68 yen         28.45 yen  
  Ann Div                                NIL           6.00 yen   
  -Q2 div            NIL                 NIL                      
  -Q4 div                                NIL           6.00 yen   
  
  NOTE - Immuno Biological Laboratories Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T

Recent news on Immuno-Biological Laboratories

See all news